Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Stock Holdings Lowered by Toroso Investments LLC

Toroso Investments LLC reduced its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA – Get Rating) by 16.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 66,372 shares of the pharmacy operator’s stock after selling 13,388 shares during the quarter. Toroso Investments LLC’s holdings in Walgreens Boots Alliance were worth $2,084,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the business. Blume Capital Management Inc. raised its holdings in Walgreens Boots Alliance by 35.7% during the 3rd quarter. Blume Capital Management Inc. now owns 950 shares of the pharmacy operator’s stock worth $30,000 after buying an additional 250 shares during the period. Roberts Glore & Co. Inc. IL raised its holdings in Walgreens Boots Alliance by 1.5% during the 2nd quarter. Roberts Glore & Co. Inc. IL now owns 20,511 shares of the pharmacy operator’s stock worth $778,000 after buying an additional 295 shares during the period. CWM LLC raised its holdings in Walgreens Boots Alliance by 1.3% during the 3rd quarter. CWM LLC now owns 24,189 shares of the pharmacy operator’s stock worth $760,000 after buying an additional 306 shares during the period. Candriam Luxembourg S.C.A. raised its holdings in Walgreens Boots Alliance by 0.5% during the 1st quarter. Candriam Luxembourg S.C.A. now owns 63,483 shares of the pharmacy operator’s stock worth $2,842,000 after buying an additional 310 shares during the period. Finally, Veriti Management LLC raised its holdings in Walgreens Boots Alliance by 2.2% during the 3rd quarter. Veriti Management LLC now owns 14,807 shares of the pharmacy operator’s stock worth $465,000 after buying an additional 312 shares during the period. 56.71% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Stock Down 0.4 %

WBA stock opened at $33.41 on Friday. The company has a quick ratio of 0.36, a current ratio of 0.70 and a debt-to-equity ratio of 0.32. The company has a fifty day moving average price of $35.93 and a two-hundred day moving average price of $36.47. Walgreens Boots Alliance, Inc. has a one year low of $30.39 and a one year high of $48.62.

Walgreens Boots Alliance (NASDAQ:WBA – Get Rating) last released its quarterly earnings data on Thursday, January 5th. The pharmacy operator reported $1.16 EPS for the quarter, topping analysts’ consensus estimates of $1.15 by $0.01. Walgreens Boots Alliance had a negative net margin of 2.24% and a positive return on equity of 13.57%. The firm had revenue of $33.38 billion during the quarter, compared to analysts’ expectations of $33.04 billion. During the same period in the previous year, the business posted $1.68 earnings per share. The company’s revenue for the quarter was down 1.5% compared to the same quarter last year. Equities analysts anticipate that Walgreens Boots Alliance, Inc. will post 4.5 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 10th. Stockholders of record on Thursday, February 16th were issued a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 5.75%. The ex-dividend date of this dividend was Wednesday, February 15th. Walgreens Boots Alliance’s dividend payout ratio is currently -55.81%.

Analysts Set New Price Targets

Several brokerages have recently weighed in on WBA. Cowen raised shares of Walgreens Boots Alliance from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $43.00 to $54.00 in a research note on Tuesday, November 22nd. Credit Suisse Group decreased their price target on shares of Walgreens Boots Alliance from $42.00 to $41.00 and set a “neutral” rating for the company in a research note on Friday, January 6th. UBS Group raised their price target on shares of Walgreens Boots Alliance to $40.00 in a research note on Monday, November 28th. Cowen raised shares of Walgreens Boots Alliance from a “market perform” rating to an “outperform” rating and raised their price target for the stock from $43.00 to $54.00 in a research note on Tuesday, November 22nd. Finally, Mizuho raised their price target on shares of Walgreens Boots Alliance from $36.00 to $41.00 and gave the stock a “neutral” rating in a research note on Wednesday, December 14th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $43.43.

Walgreens Boots Alliance Profile

(Get Rating)

Walgreens Boots Alliance, Inc engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment.